Morita Miwa, Joyce Daniel, Miller Charles, Fung John J, Lu Lina, Qian Shiguang
Department of Immunology, Lerner Research InstituteCleveland Clinic, Cleveland, OH.
Department of General Surgery, Transplant Center, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH.
Hepatology. 2015 Sep;62(3):915-31. doi: 10.1002/hep.27909. Epub 2015 Jul 30.
Liver tolerance was initially recognized by the spontaneous acceptance of liver allografts in many species. The underlying mechanisms are not completely understood. However, liver transplant (LT) tolerance absolutely requires interferon (IFN)-γ, a rejection-associated inflammatory cytokine. In this study, we investigated the rejection of liver allografts deficient in the IFN-γ receptor and reveal that the liver graft is equipped with machineries capable of counterattacking the host immune response through a mesenchyme-mediated immune control (MMIC) mechanism. MMIC is triggered by T effector (Tef) cell-derived IFN-γ that drives expression of B7-H1 on graft mesenchymal cells leading to Tef cell apoptosis. We describe the negative feedback loop between graft mesenchymal and Tef cells that ultimately results in LT tolerance. Comparable elevations of T-regulatory cells and myeloid-derived suppressor cells were observed in both rejection and tolerance groups and were not dependent on IFN-γ stimulation, suggesting a critical role of Tef cell elimination in tolerance induction. We identify potent MMIC activity in hepatic stellate cells and liver sinusoidal endothelial cells. MMIC is unlikely exclusive to the liver, given that spontaneous acceptance of kidney allografts has been reported, although less commonly, probably reflecting variance in MMIC activity.
MMIC may represent an important homeostatic mechanism that supports peripheral tolerance and could be a target for the prevention and treatment of transplant rejection. This study highlights that the graft is an active participant in the equipoise between tolerance and rejection and warrants more attention in the search for tolerance biomarkers.
肝脏耐受性最初是通过许多物种对肝脏同种异体移植的自发接受而被认识到的。其潜在机制尚未完全了解。然而,肝脏移植(LT)耐受性绝对需要干扰素(IFN)-γ,一种与排斥相关的炎性细胞因子。在本研究中,我们研究了缺乏IFN-γ受体的肝脏同种异体移植的排斥反应,并揭示肝脏移植物具备通过间充质介导的免疫控制(MMIC)机制反击宿主免疫反应的机制。MMIC由效应T(Tef)细胞衍生的IFN-γ触发,该IFN-γ驱动移植物间充质细胞上B7-H1的表达,导致Tef细胞凋亡。我们描述了移植物间充质细胞和Tef细胞之间的负反馈回路,最终导致LT耐受性。在排斥组和耐受组中均观察到调节性T细胞和髓系来源的抑制细胞有相当程度的升高,且不依赖于IFN-γ刺激,这表明Tef细胞清除在耐受性诱导中起关键作用。我们在肝星状细胞和肝窦内皮细胞中鉴定出强大的MMIC活性。鉴于已有报道称肾脏同种异体移植可自发被接受,尽管不太常见,MMIC不太可能是肝脏所特有的,这可能反映了MMIC活性的差异。
MMIC可能代表一种重要的稳态机制,支持外周耐受性,并且可能成为预防和治疗移植排斥的靶点。本研究强调移植物是耐受性和排斥反应平衡中的积极参与者,在寻找耐受性生物标志物时值得更多关注。